CCL2 and breast cancer: Of particular interest in HR+ BC is the role of estrogen signaling: emerging data suggest estrogen can boost the expression of CXCL8 and CCL2, which in turn enhances neutrophil trafficking into the TME, thus reinforcing the N2 phenotype [76].